![Richard van Etten](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard van Etten
Director/Miembro de la Junta en Helio Genomics, Inc. .
Perfil
Richard van Etten currently works at Helio Genomics, Inc., as Chief Medical Advisor & Director.
Cargos activos de Richard van Etten
Empresas | Cargo | Inicio |
---|---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Technology Services |
- Bolsa de valores
- Insiders
- Richard van Etten